The Pharmacogenomics Journal - Table of Contents alert Volume 17 Issue 6

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 17, Issue 6 (December 2017) In this issue Letter to the Editor Review Original Articles Retraction Also new AOP   Sign up for e-alerts Recommend to your library Web feed Subscribe   Letter to the Editor Top HLA-B18 as risk factor of liver fibrosis progression in HIV/HCV treatment-experienced patients M Frías, D Rodríguez-Cano, F Cuenca-López, J Macías, A Gordon, B Manzanares-Martín, J A Pineda, Á Camacho, J Torre-Cisneros, J Peña, A Rivero-Juárez and A Rivero Pharmacogenomics J 2017 17: 479-480; advance online publication, October 25, 2016; 10.1038/tpj.2016.80 Full Text Review Top CYP3A4 is a crosslink between vitamin D and calcineurin inhibitors in solid organ transplant recipients: implications for bone health A Prytuła, K Cransberg and A Raes Pharmacogenomics J 2017 17: 481-487; advance online publication, April 18, 2017; 10.1038/tpj.2017.15 Abstract | Full Text Original Articles Top Comparing cytochrome P450 pharmacogenetic information available on United States drug labels and European Union Summaries of Product Characteristics J Reis-Pardal, A Rodrigues, E Rodrigues and F Fernandez-Llimos Pharmacogenomics J 2017 17: 488-493; advance online publication, May 31, 2016; 10.1038/tpj.2016.40 Abstract | Full Text Population differences in S-warfarin pharmacokinetics among African Americans, Asians and whites: their influence on pharmacogenetic dosing algorithms K Kubo, M Ohara, M Tachikawa, L H Cavallari, M T M Lee, M S Wen, M G Scordo, E A Nutescu, M A Perera, A Miyajima, N Kaneko, V Pengo, R Padrini, Y T Chen and H Takahashi Pharmacogenomics J 2017 17: 494-500; advance online publication, August 9, 2016; 10.1038/tpj.2016.57 Abstract | Full Text HLA-B*51:01 is strongly associated with clindamycin-related cutaneous adverse drug reactions Y Yang, S Chen, F Yang, L Zhang, G Alterovitz, H Zhu, J Xuan, X Yang, H Luo, J Mu, L He, X Luo and Q Xing Pharmacogenomics J 2017 17: 501-505; advance online publication, August 16, 2016; 10.1038/tpj.2016.61 Abstract | Full Text Predictive value of ATP7b, BRCA1, BRCA2, PARP1, UIMC1 (RAP80), HOXA9, DAXX, TXN (TRX1), THBS1 (TSP1) and PRR13 (TXR1) genes in patients with epithelial ovarian cancer who received platinum-taxane first-line therapy S Pontikakis, C Papadaki, M Tzardi, M Trypaki, M Sfakianaki, F Koinis, E Lagoudaki, L Giannikaki, A Kalykaki, E Kontopodis, Z Saridaki, N Malamos, V Georgoulias and J Souglakos Pharmacogenomics J 2017 17: 506-514; advance online publication, October 25, 2016; 10.1038/tpj.2016.63 Abstract | Full Text Promoter region variation in NFE2L2 influences susceptibility to ototoxicity in patients exposed to high cumulative doses of cisplatin T F Spracklen, A A Vorster, L Ramma, S Dalvie and R S Ramesar Pharmacogenomics J 2017 17: 515-520; advance online publication, July 26, 2016; 10.1038/tpj.2016.52 Abstract | Full Text Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancer D L Hertz, K M Kidwell, N J Seewald, C L Gersch, Z Desta, D A Flockhart, A-M Storniolo, V Stearns, T C Skaar, D F Hayes, N L Henry and J M Rae Pharmacogenomics J 2017 17: 521-527; advance online publication, August 23, 2016; 10.1038/tpj.2016.60 Abstract | Full Text Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancer Y Sunakawa, S Cao, N B Volz, M D Berger, D Yang, A Parekh, W Zhang, S Matsusaka, Y Ning, S Stremitzer, S Stintzing, A Sebio, S Okazaki, T Wakatsuki, M Azuma, M Watanabe, W Koizumi, A H Wu and H-J Lenz Pharmacogenomics J 2017 17: 528-534; advance online publication, May 31, 2016; 10.1038/tpj.2016.46 Abstract | Full Text Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysis E K Morgen, H-J Lenz, D J Jonker, D Tu, G Milano, F Graziano, J Zalcberg, C S Karapetis, A Dobrovic, C J O’Callaghan and G Liu Pharmacogenomics J 2017 17: 535-542; advance online publication, November 29, 2016; 10.1038/tpj.2016.56 Abstract | Full Text CXCR4 polymorphism predicts progression-free survival in metastatic colorectal cancer patients treated with first-line bevacizumab-based chemotherapy S Matsusaka, S Cao, D L Hanna, Y Sunakawa, M Ueno, N Mizunuma, W Zhang, D Yang, Y Ning, S Stintzing, A Sebio, S Stremitzer, S Yamauchi, A Parekh, S Okazaki, M D Berger, R El-Khoueiry, A Mendez, W Ichikawa, F Loupakis and H-J Lenz Pharmacogenomics J 2017 17: 543-550; advance online publication, August 9, 2016; 10.1038/tpj.2016.59 Abstract | Full Text HLA-B18 as a risk factor of short-term progression to severe liver fibrosis in HIV/HCV co-infected patients with absent or minimal fibrosis: implications for timing of therapy M Frías, D Rodríguez-Cano, F Cuenca-López, J Macías, A Gordon, B Manzanares-Martín, J A Pineda, Á Camacho, J Torre-Cisneros, J Peña, A Rivero-Juárez and A Rivero Pharmacogenomics J 2017 17: 551-555; advance online publication, May 31, 2016; 10.1038/tpj.2016.42 Abstract | Full Text Effect of ABCB1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotype T Vanhove, P Annaert, D Lambrechts and D R J Kuypers Pharmacogenomics J 2017 17: 556-562; advance online publication, July 5, 2016; 10.1038/tpj.2016.49 Abstract | Full Text Retraction Top Chronic fluoxetine upregulates activity, protein and mRNA levels of cytosolic phospholipase A2 in rat frontal cortex J S Rao, R N Ertley, H-J Lee, S I Rapoport and R P Bazinet Pharmacogenomics J 2017 17: 563; advance online publication, October 17, 2017; 10.1038/tpj.2017.42 Full Text   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to The Pharmacogenomics Journal. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.